Theologou M, Perez-Ruiz J, Varoutis P, Flaris N, Skoulios N

Idioma: Ingles.
Referencias bibliográficas: 19
Paginas: 15-19
Archivo PDF: 484.26 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Machinis TG, Fountas KN, Dimopoulos V, Robinson JS. History ofacoustic neurinoma surgery. Neurosurg Focus. 2005;18(4):e9.

2. Figueiredo EG, Soga Y, Amorim RL, Oliveira AM, Teixeira MJ.The puzzling olfactory groove schwannoma: a systematic review.Skull Base. 2011;21(1):31-6.

3. Park JY, Park H, Park NJ, Park JS, Sung H-J, Lee SS. Use ofCalretinin, CD56, and CD34 for Differential Diagnosis ofSchwannoma and Neurofibroma. The Korean Journal ofPathology. 2011; 45(1).

4. Ohashi R, Wakayama N, Kawamoto M, Tsuchiya S, Okubo K.Solitary nasal schwannoma: Usefulness of CD34 and calretininstaining for distinction from histological mimics. J Nippon MedSch. 2013; 80(4):300-6.

5. Hirose T, Tani T, Shimada T, Ishizawa K, Shimada S, Sano T.Immunohistochemical demonstration of EMA/Glut1-positiveperineurial cells and CD34-positive fibroblastic cells in peripheralnerve sheath tumors. Mod Pathol. 2003; 16(4):293-8.

6. Masuda H, Nemoto M, Okonogi S, Node Y, Ando S, KondoK, et al. Utility of Schwann/2E and Sox10 in distinguishingCD57-negative olfactory groove schwannoma from olfactoryensheathing cell tumor: A case report and review of the literature.Neuropathology. 2020;40(4):373-8.

7. Kasymov AR, Rzaev DA, Kalinovsky AV, Voronina EI. Olfactory(subfrontal) schwannoma: case report and literature review. ZhVopr Neirokhir Im N N Burdenko. 2022;86(3):50-5.

8. Liu S, Liu S, Liu Q, Yu L, Yu P, Sun S, et al. Schwannoma inthe Olfactory Groove: Two Case Reports. Ear Nose Throat J.2022:1455613221139405.

9. Sauvaget F, Francois P, Ben Ismail M, Thomas C, Velut S.Anterior fossa schwannoma mimicking an olfactory groovemeningioma: case report and literature review. Neurochirurgie.2013;59(2):75-80.

10. Murtaza M, Chacko A, Delbaz A, Reshamwala R, Rayfield A,McMonagle B, et al. Why are olfactory ensheathing cell tumorsso rare? Cancer Cell Int. 2019;19:260.

11. Russel DSR. Pathology of Tumors of the Nervous System. 3rd ed:London: E Arnold; 1971.

12. D'Almeida Costa F, Dias TM, Lombardo KA, Raghunathan A,Giannini C, Kenyon L, et al. Intracranial cellular schwannomas:a clinicopathological study of 20 cases. Histopathology.2020;76(2):275-82.

13. Perry A, Reus D, Rodriguez F. Neurofibroma. In: Tumors STaB,editor. WHO Classification of Tumors 5th ed: WHO; 2019. p.232-6.

14. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology ofperipheral nerve sheath tumors: diagnostic overview andupdate on selected diagnostic problems. Acta Neuropathol.2012;123(3):295-319.

15. Chaubal A, Paetau A, Zoltick P, Miettinen M. CD34immunoreactivity in nervous system tumors. Acta Neuropathol.1994;88(5):454-8.

16. Tosaka M, Hirato J, Miyagishima T, Saito N, Nakazato Y, SasakiT. Calcified vestibular schwannoma with unusual histologicalcharacteristics - positive immunoreactivity for CD-34 antigen.Acta Neurochir (Wien). 2002;144(4):395-9.

17. Khalifa MA, Montgomery EA, Ismiil N, Azumi N. What are theCD34+ cells in benign peripheral nerve sheath tumors? Doubleimmunostaining study of CD34 and S-100 protein. Am J ClinPathol. 2000;114(1):123-6.

18. Weiss SW, Nickoloff BJ. CD-34 Is Expressed by a DistinctiveCell Population in Peripheral Nerve, Nerve Sheath Tumors, andRelated Lesions. The American Journal of Surgical Pathology. 1993;17(10):1039-45.

19. Zhou H, Coffin CM, Perkins SL, Tripp SR, Liew M, ViskochilDH. Malignant peripheral nerve sheath tumor: a comparisonof grade, immunophenotype, and cell cycle/growth activationmarker expression in sporadic and neurofibromatosis 1-relatedlesions. Am J Surg Pathol. 2003;27(10):1337-45.